Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × Endoscopy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Barrett Esophagus 13 Esophageal Neoplasms 7 Rectal Neoplasms 6 Colorectal Neoplasms 6 Adenocarcinoma Of Esophagus 6 Nasopharyngeal Carcinoma 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Polyps 3 Precancerous Conditions 2 Pathologic Complete Response 2 Lung Neoplasms 2 Hyperplasia 2 Gastroesophageal Reflux 2 Adenomatous Polyposis Coli 2 Adenocarcinoma 2 Urogenital Neoplasms 1 Upper Tract Urothelial Carcinoma 1 Thyroid Neoplasms 1 Stomach Ulcer 1 Stomach Diseases 1 Recurrence 1 Polyposis, Gastric 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Metaplasia 1 Melanoma 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Lymphoma, AIDS-Related 1

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Specimen Handling 15 Nivolumab 15 Cetuximab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 130-nm albumin-bound paclitaxel 10 Platinum 9 Bevacizumab 9 osimertinib 8 Sunitinib 8 Sorafenib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡